Jason Barker, ND

home / authors / jason-barker-nd

Clinical Lab Educator at Vibrant Wellness.

Articles

Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics

Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics

Sophia Abene;Jason Barker, ND
May 9th 2025

Vibrant Wellness’ Jason Barker, ND, outlines prevention measures, diagnostic red flags, and advances in multiplex testing for tick-borne diseases.

Read More

New Microarray Technology Overcomes Limitations of Standard Lyme Disease Testing

New Microarray Technology Overcomes Limitations of Standard Lyme Disease Testing

Sophia Abene;Jason Barker, ND
May 5th 2025

Jason Barker, ND, details how Vibrant’s platform raises diagnostic sensitivity from 63% to 100%, ensuring more accurate detection and faster treatment for Lyme disease and tick-borne infections.

Read More

New Microarray Platform Aims to Improve Tick-Borne Disease Diagnosis

New Microarray Platform Aims to Improve Tick-Borne Disease Diagnosis

Sophia Abene;Jason Barker, ND
May 1st 2025

Jason Barker, ND, explains how standard testing can miss coinfections and how Vibrant’s microarray improves sensitivity and efficiency in a single test.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Computational Model Maps Over 67,000 Malaria Epitopes to Improve Vaccine Targeting
Published: May 20th 2025 | Updated: May 23rd 2025
Computational Model Maps Over 67,000 Malaria Epitopes to Improve Vaccine Targeting
With Its Global Bacterial Meningitis Guidelines, WHO Aims to Speed Up Diagnosis, Treatment
Published: May 19th 2025 | Updated: May 23rd 2025
With Its Global Bacterial Meningitis Guidelines, WHO Aims to Speed Up Diagnosis, Treatment
Ceftobiprole Launches Commercially in US
Published: May 20th 2025 | Updated: May 23rd 2025
Ceftobiprole Launches Commercially in US
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
Published: May 14th 2025 | Updated: May 23rd 2025
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
Published: May 16th 2025 | Updated: May 23rd 2025
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
© 2025 MJH Life Sciences

All rights reserved.